Treatment of adult T-cell leukaemia-lymphoma with irinotecan hydrochloride (CPT-11). CPT-11 Study Group on Hematological Malignancy.

A late phase II study of a new camptothecin analogue, irinotecan hydrochloride (CPT-11), was conducted to evaluate the anti-tumour effect and toxicity in patients with refractory leukaemia and lymphoma including adult T-cell leukaemia (ATL)-lymphoma, in a multi-institutional cooperative study. All t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuda, H., Takatsuki, K., Ohno, R., Masaoka, T., Okada, K., Shirakawa, S., Ohashi, Y., Ota, K.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033383/
https://www.ncbi.nlm.nih.gov/pubmed/7917938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033383/
https://www.ncbi.nlm.nih.gov/pubmed/7917938

Ejemplares similares